NasdaqGS - Delayed Quote USD
Revolution Medicines, Inc. (RVMD)
41.09
+0.89
+(2.21%)
At close: June 6 at 4:00:00 PM EDT
41.09
0.00
(0.00%)
After hours: June 6 at 5:59:47 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 9 | 9 |
| Avg. Estimate | -1.12 | -1.17 | -4.65 | -4.98 |
| Low Estimate | -1.18 | -1.22 | -4.81 | -5.4 |
| High Estimate | -1.01 | -1.04 | -4.09 | -4.09 |
| Year Ago EPS | -0.81 | -0.94 | -3.58 | -4.65 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | 500k | 500k | 1.5M | 4.61M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 4.5M | 4.5M | 13.5M | 41.5M |
| Year Ago Sales | -- | -- | -- | 1.5M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 207.41% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.76 | -0.88 | -0.96 | -1.06 |
| EPS Actual | -0.81 | -0.94 | -1.12 | -1.13 |
| Difference | -0.05 | -0.06 | -0.16 | -0.07 |
| Surprise % | -6.29% | -7.00% | -16.12% | -7.02% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.12 | -1.17 | -4.65 | -4.98 |
| 7 Days Ago | -1.12 | -1.17 | -4.65 | -4.98 |
| 30 Days Ago | -1.09 | -1.13 | -4.48 | -4.72 |
| 60 Days Ago | -1.09 | -1.13 | -4.48 | -4.7 |
| 90 Days Ago | -1.07 | -1.11 | -4.42 | -4.66 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 1 | 2 |
| Up Last 30 Days | 1 | 2 | 1 | 2 |
| Down Last 7 Days | 5 | 4 | 8 | 6 |
| Down Last 30 Days | 5 | 4 | 8 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RVMD | -38.40% | -24.83% | -29.96% | -7.14% |
| S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/14/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/8/2025 |
| Maintains | Guggenheim: Buy to Buy | 5/8/2025 |
| Reiterates | Needham: Buy to Buy | 5/8/2025 |
| Reiterates | Wedbush: Outperform to Outperform | 4/28/2025 |
| Reiterates | Needham: Buy to Buy | 4/8/2025 |
Related Tickers
NRIX Nurix Therapeutics, Inc.
12.78
+2.24%
RLAY Relay Therapeutics, Inc.
3.3600
+3.70%
AKRO Akero Therapeutics, Inc.
54.28
+0.63%
PTGX Protagonist Therapeutics, Inc.
54.38
+1.04%
STOK Stoke Therapeutics, Inc.
11.14
+2.39%
PCVX Vaxcyte, Inc.
36.99
+6.29%
ORIC ORIC Pharmaceuticals, Inc.
9.32
+1.75%
NUVL Nuvalent, Inc.
78.02
-0.09%
CYTK Cytokinetics, Incorporated
32.30
+0.69%
CRNX Crinetics Pharmaceuticals, Inc.
33.01
+2.13%